The June 18, 2015, joint meeting of the NCATS Advisory Council and the Cures Acceleration Network Review Board featured the following meeting materials.
Presentations
- NCATS Director’s Report (PDF - 4MB) – Christopher P. Austin, M.D., director, NCATS
- Discovering New Therapeutic Uses for Existing Molecules Program (PDF - 240KB) – Christine M. Colvis, Ph.D., director, drug development partnership programs, NCATS
- Inhibition of Fyn Kinase for Disease-Modifying Therapy of Alzheimer’s Disease (PDF - 4MB) – Stephen M. Strittmatter, M.D., Ph.D., professor of neurology and neurobiology; director, cellular neuroscience, Yale University
- Subcommittee Report on Pharma/BioTech/Venture (PBV) Groups (PDF - 77KB) – Ankit A. Mahadevia, M.D., M.B.A., venture partner, Atlas Venture, and Freda C. Lewis-Hall, M.D., chief medical officer, Pfizer
- Concept Clearance: NCATS Exploratory Clinical Trials for Small Business (PDF - 111KB) – Lili M. Portilla, M.P.A., director, strategic alliances, NCATS
- Concept Clearance: Small Business Translational Science Innovation Award Program (PDF - 117KB) – Philip J. Brooks, Ph.D., program director, Division of Clinical Innovation, NCATS, and Lili M. Portilla, M.P.A., director, strategic alliances, NCATS
- Concept Clearance: Development of Stem Cell- or iPS Cell-Based Assays for Compound Toxicity Evaluation (PDF - 134KB) – Menghang Xia, Ph.D., leader, systems toxicology, Toxicology in the 21st Century, Division of Preclinical Innovation, NCATS; Lili M. Portilla, M.P.A., director, strategic alliances, NCATS; and Anna Rossoshek, M.S., M.B.A., branch and program manager, Chemical Genomics Branch, NCATS Chemical Genomics Center, Division of Preclinical Innovation, NCATS
- Concept Clearance: Development of Smart Plate Technology (PDF - 118KB) – Sam Michael, Ph.D., acting chief information officer and director, automation and compound management, NCATS; Lili M. Portilla, M.P.A., director, strategic alliances, NCATS; and Anna Rossoshek, M.S., M.B.A., branch and program manager, Chemical Genomics Branch, NCATS Chemical Genomics Center, Division of Preclinical Innovation, NCATS
- Concept Clearance: R&D Contract Support for NCATS Translational Sciences (PDF - 116KB) – Anton M. Simeonov, Ph.D., acting scientific director, NCATS
- Concept Clearance: Tissues-on-Chips, Part II (PDF - 222KB) – Danilo A. Tagle, Ph.D., M.S., associate director for special initiatives, NCATS
- Concept Clearance: Administrative Supplements for Collaborative Innovation in the CTSA Program (PDF - 125KB) – Philip J. Brooks, Ph.D., program director, Division of Clinical Innovation, NCATS
- The CTSA Program: Collaborative Innovation for Translational Research (PDF - 862KB) – Petra Kaufmann, M.D., M.Sc., director, Division of Clinical Innovation, NCATS
Additional Meeting Information
- Agenda (PDF - 70KB)
- Videocast
- Minutes (PDF - 253KB)
- Federal Register Notice
- Concept Clearances